Literature DB >> 22989185

Modeling of open, closed, and open-inactivated states of the hERG1 channel: structural mechanisms of the state-dependent drug binding.

Serdar Durdagi1, Sumukh Deshpande, Henry J Duff, Sergei Y Noskov.   

Abstract

The human ether-a-go-go related gene 1 (hERG1) K ion channel is a key element for the rapid component of the delayed rectified potassium current in cardiac myocytes. Since there are no crystal structures for hERG channels, creation and validation of its reliable atomistic models have been key targets in molecular cardiology for the past decade. In this study, we developed and vigorously validated models for open, closed, and open-inactivated states of hERG1 using a multistep protocol. The conserved elements were derived using multiple-template homology modeling utilizing available structures for Kv1.2, Kv1.2/2.1 chimera, and KcsA channels. Then missing elements were modeled with the ROSETTA De Novo protein-designing suite and further refined with all-atom molecular dynamics simulations. The final ensemble of models was evaluated for consistency to the reported experimental data from biochemical, biophysical, and electrophysiological studies. The closed state models were cross-validated against available experimental data on toxin footprinting with protein-protein docking using hERG state-selective toxin BeKm-1. Poisson-Boltzmann calculations were performed to determine gating charge and compare it to electrophysiological measurements. The validated structures offered us a unique chance to assess molecular mechanisms of state-dependent drug binding in three different states of the channel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22989185     DOI: 10.1021/ci300353u

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  29 in total

1.  Molecular Simulations of Solved Co-crystallized X-Ray Structures Identify Action Mechanisms of PDEδ Inhibitors.

Authors:  Ramin Ekhteiari Salmas; Mert Mestanoglu; Mine Yurtsever; Sergei Y Noskov; Serdar Durdagi
Journal:  Biophys J       Date:  2015-09-01       Impact factor: 4.033

Review 2.  Towards a Structural View of Drug Binding to hERG K+ Channels.

Authors:  Jamie I Vandenberg; Eduardo Perozo; Toby W Allen
Journal:  Trends Pharmacol Sci       Date:  2017-07-12       Impact factor: 14.819

3.  Hydrophobic plug functions as a gate in voltage-gated proton channels.

Authors:  Adam Chamberlin; Feng Qiu; Santiago Rebolledo; Yibo Wang; Sergei Y Noskov; H Peter Larsson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-30       Impact factor: 11.205

4.  NS1643 interacts around L529 of hERG to alter voltage sensor movement on the path to activation.

Authors:  Jiqing Guo; Yen May Cheng; James P Lees-Miller; Laura L Perissinotti; Tom W Claydon; Christina M Hull; Samrat Thouta; Daniel E Roach; Serdar Durdagi; Sergei Y Noskov; Henry J Duff
Journal:  Biophys J       Date:  2015-03-24       Impact factor: 4.033

5.  Challenges and advances in atomistic simulations of potassium and sodium ion channel gating and permeation.

Authors:  Kevin R DeMarco; Slava Bekker; Igor Vorobyov
Journal:  J Physiol       Date:  2018-12-19       Impact factor: 5.182

Review 6.  Getting to the heart of hERG K(+) channel gating.

Authors:  Matthew D Perry; Chai-Ann Ng; Stefan A Mann; Arash Sadrieh; Mohammad Imtiaz; Adam P Hill; Jamie I Vandenberg
Journal:  J Physiol       Date:  2015-06-15       Impact factor: 5.182

7.  Prediction of hERG Liability - Using SVM Classification, Bootstrapping and Jackknifing.

Authors:  Hongmao Sun; Ruili Huang; Menghang Xia; Sampada Shahane; Noel Southall; Yuhong Wang
Journal:  Mol Inform       Date:  2016-12-21       Impact factor: 3.353

8.  Assessing hERG1 Blockade from Bayesian Machine-Learning-Optimized Site Identification by Ligand Competitive Saturation Simulations.

Authors:  Mahdi Mousaei; Meruyert Kudaibergenova; Alexander D MacKerell; Sergei Noskov
Journal:  J Chem Inf Model       Date:  2020-11-16       Impact factor: 4.956

9.  Pore dynamics and conductance of RyR1 transmembrane domain.

Authors:  David Shirvanyants; Srinivas Ramachandran; Yingwu Mei; Le Xu; Gerhard Meissner; Nikolay V Dokholyan
Journal:  Biophys J       Date:  2014-06-03       Impact factor: 4.033

10.  Pharmacokinetic-pharmacodynamic modelling of drug-induced QTc interval prolongation in man: prediction from in vitro human ether-à-go-go-related gene binding and functional inhibition assays and conscious dog studies.

Authors:  V F S Dubois; E Casarotto; M Danhof; O Della Pasqua
Journal:  Br J Pharmacol       Date:  2016-09-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.